Singha Souvik, Cavallaro Julianna, Wong Tamika, Albers Olivia, Ali Samer, Zlochower Avraham, Andrews Robert, Boockvar John
Department of Neurosurgery, Lenox Hill Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, USA.
Department of Pathology, Lenox Hill Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, USA.
Cureus. 2025 Apr 1;17(4):e81566. doi: 10.7759/cureus.81566. eCollection 2025 Apr.
Recurrent glioblastoma multiforme (GBM) is associated with a very poor prognosis due to the limited efficacy of existing therapies and constraints of blood-brain barrier (BBB) permeability. Particularly in the recurrent setting, there is no uniform standard of care treatment. In one of the proposed treatments for recurrent GBM, a laparoscopically harvested omental free tissue autograft is used to favor neovascularization and bypass the BBB, in which patients receive an autologous abdominal omental tissue intracranially following attempted gross total resection of the tumor. In this paper, we report the long-term survival and follow-up data of a patient who underwent this procedure. The progression-free and overall survival were 21 months and 30 months, respectively. We hypothesize that neovascularization from the omental flap helps bypass the BBB, and omental-derived autologous immune cells help penetrate the tumor microenvironment and recognize tumor-associated antigens, thus providing better tumor control for recurrent GBM.
复发性多形性胶质母细胞瘤(GBM)由于现有治疗方法疗效有限以及血脑屏障(BBB)通透性的限制,预后非常差。特别是在复发情况下,没有统一的标准护理治疗方法。在一种针对复发性GBM的提议治疗方法中,通过腹腔镜获取的游离大网膜组织自体移植用于促进新血管形成并绕过血脑屏障,即患者在尝试对肿瘤进行大体全切后,将自体腹部大网膜组织植入颅内。在本文中,我们报告了一名接受该手术患者的长期生存情况和随访数据。无进展生存期和总生存期分别为21个月和30个月。我们推测,大网膜瓣的新血管形成有助于绕过血脑屏障,而大网膜来源的自体免疫细胞有助于穿透肿瘤微环境并识别肿瘤相关抗原,从而为复发性GBM提供更好的肿瘤控制。